TORRENT PHARMACEUTICALS
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Established
- 1959-01-01
- Employees
- -
- Market Cap
- $13.7B
Key Trastuzumab Biosimilars Market Trend 2024-2033: Focus on New Product Launches
Trastuzumab biosimilars market to grow from $4.27B in 2023 to $5.43B in 2024, reaching $14.69B by 2028, driven by market expansion, patent expirations, and competitive pricing.
Torrent Pharma Fined Rs 6.32 Lakh by NPPA for Price Violation
Torrent Pharmaceuticals fined Rs 6.32 lakh by NPPA for launching a new drug without prior price approval.
© Copyright 2024. All Rights Reserved by MedPath